☰

Daniel R. Wahl, Ph.D. - Publications

Affiliations: 
2012 University of Michigan, Ann Arbor, Ann Arbor, MI 
Area:
anti-DNA autoantibody structure and function, and the identification of novel molecular targets and small molecules for the treatment of autoimmune diseases and cancer
Tree Info Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Bell HN, Huber AK, Singhal R, Korimerla N, Rebernick RJ, Kumar R, El-Derany MO, Sajjakulnukit P, Das NK, Kerk SA, Solanki S, James JG, Kim D, Zhang L, Chen B, ... ... Wahl DR, et al. Microenvironmental ammonia enhances T cell exhaustion in colorectal cancer. Cell Metabolism. PMID 36528023 DOI: 10.1016/j.cmet.2022.11.013  0.341
2020 Werner CK, Nna UJ, Sun H, Wilder-Romans K, Dresser J, Kothari AU, Zhou W, Yao Y, Rao A, Stallard S, Koschmann C, Bor T, Debinski W, Hegedus AM, Morgan MA, ... ... Wahl DR, et al. Expression of the of the androgen receptor governs radiation resistance in a subset of glioblastomas vulnerable to anti-androgen therapy. Molecular Cancer Therapeutics. PMID 32796101 DOI: 10.1158/1535-7163.Mct-20-0095  0.305
2020 Chung C, Sweha SR, Pratt D, Tamrazi B, Panwalkar P, Banda A, Bayliss J, Hawes D, Yang F, Lee HJ, Shan M, Cieslik M, Qin T, Werner CK, Wahl DR, et al. Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas. Cancer Cell. PMID 32795401 DOI: 10.1016/J.Ccell.2020.07.008  0.331
2020 Zhou W, Yao Y, Scott AJ, Wilder-Romans K, Dresser JJ, Werner CK, Sun H, Pratt D, Sajjakulnukit P, Zhao SG, Davis M, Nelson BS, Halbrook CJ, Zhang L, Gatto F, ... ... Wahl DR, et al. Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. Nature Communications. 11: 3811. PMID 32732914 DOI: 10.1038/S41467-020-17512-X  0.319
2020 Michmerhuizen AR, Chandler B, Olsen E, Wilder-Romans K, Moubadder L, Liu M, Pesch AM, Zhang A, Ritter C, Ward ST, Santola A, Nyati S, Rae JM, Hayes D, Feng FY, ... ... Wahl D, et al. Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells. Frontiers in Endocrinology. 11: 35. PMID 32117061 DOI: 10.3389/Fendo.2020.00035  0.317
2020 Nelson BS, Lin L, Kremer DM, Sousa CM, Cotta-Ramusino C, Myers A, Ramos J, Gao T, Kovalenko I, Wilder-Romans K, Dresser J, Davis M, Lee HJ, Nwosu ZC, Campit S, ... ... Wahl DR, et al. Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy. Cancer & Metabolism. 8: 1. PMID 31908776 DOI: 10.1186/S40170-019-0202-2  0.31
2019 Halbrook CJ, Wahl DR, Lyssiotis CA. Running the Light: Nucleotide Metabolism Drives Bypass of Senescence in Cancer. Trends in Biochemical Sciences. PMID 31699584 DOI: 10.1016/J.Tibs.2019.10.007  0.3
2019 Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, Liao P, Zhou J, Zhang Q, Dow A, Saripalli AL, Kryczek I, Wei S, Szeliga W, Vatan L, ... ... Wahl DR, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discovery. PMID 31554642 DOI: 10.1158/2159-8290.Cd-19-0338  0.347
2019 Zhou W, Wahl DR. Metabolic Abnormalities in Glioblastoma and Metabolic Strategies to Overcome Treatment Resistance. Cancers. 11. PMID 31450721 DOI: 10.3390/Cancers11091231  0.326
2019 Zhang Q, Green MD, Lang X, Lazarus J, Parsels J, Wei S, Parsels LA, Shi J, Ramnath N, Wahl DR, Pasca di Magliano M, Frankel TL, Kryczek I, Lei Y, Lawrence TS, et al. Inhibition of ATM increases interferon signaling and sensitizes pancreatic cancer to immune checkpoint blockade therapy. Cancer Research. PMID 31101760 DOI: 10.1158/0008-5472.Can-19-0761  0.322
2019 Lowenstein PR, Orringer DA, Sagher O, Heth J, Hervey-Jumper SL, Mammoser AG, Junck L, Leung D, Umemura Y, Lawrence TS, Kim MM, Wahl DR, McKeever P, Camelo-Piragua SI, Lieberman A, et al. First-in-human phase I trial of the combination of two adenoviral vectors expressing HSV1-TK and FLT3L for the treatment of newly diagnosed resectable malignant glioma: Initial results from the therapeutic reprogramming of the brain immune system. Journal of Clinical Oncology. 37: 2019-2019. DOI: 10.1200/Jco.2019.37.15_Suppl.2019  0.345
2017 Parsels LA, Karnak D, Parsels J, Zhang Q, Vélez-Padilla J, Reichert Z, Wahl DR, Maybaum J, O'Connor MJ, Lawrence TS, Morgan MA. PARP1 Trapping and DNA Replication Stress Enhance Radiosensitization with Combined WEE1 and PARP Inhibitors. Molecular Cancer Research : McR. PMID 29133592 DOI: 10.1158/1541-7786.Mcr-17-0455  0.306
2016 Wahl DR, Dresser J, Wilder-Romans K, Parsels JD, Zhao SG, Davis M, Zhao L, Kachman M, Wernisch S, Burant CF, Morgan MA, Feng FY, Speers C, Lyssiotis CA, Lawrence TS. Glioblastoma therapy can be augmented by targeting IDH1-mediated NADPH biosynthesis. Cancer Research. PMID 27923831 DOI: 10.1158/0008-5472.Can-16-2008  0.385
2016 Reichert ZR, Wahl DR, Morgan MA. Translation of Targeted Radiation Sensitizers into Clinical Trials. Seminars in Radiation Oncology. 26: 261-70. PMID 27619248 DOI: 10.1016/J.Semradonc.2016.06.001  0.324
2015 Wahl DR, Lawrence TS. Integrating chemoradiation and molecularly targeted therapy. Advanced Drug Delivery Reviews. PMID 26596559 DOI: 10.1016/J.Addr.2015.11.007  0.317
2014 Glick GD, Rossignol R, Lyssiotis CA, Wahl D, Lesch C, Sanchez B, Liu X, Hao LY, Taylor C, Hurd A, Ferrara JL, Tkachev V, Byersdorfer CA, Boros L, Opipari AW. Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease. The Journal of Pharmacology and Experimental Therapeutics. 351: 298-307. PMID 25125579 DOI: 10.1124/Jpet.114.218099  0.686
2012 Wahl DR, Byersdorfer CA, Ferrara JL, Opipari AW, Glick GD. Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation. Immunological Reviews. 249: 104-15. PMID 22889218 DOI: 10.1111/J.1600-065X.2012.01148.X  0.654
2011 He S, Kato K, Jiang J, Wahl DR, Mineishi S, Fisher EM, Murasko DM, Glick GD, Zhang Y. Characterization of the metabolic phenotype of rapamycin-treated CD8+ T cells with augmented ability to generate long-lasting memory cells. Plos One. 6: e20107. PMID 21611151 DOI: 10.1371/Journal.Pone.0020107  0.67
2011 Gatza E, Wahl DR, Opipari AW, Sundberg TB, Reddy P, Liu C, Glick GD, Ferrara JL. Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Science Translational Medicine. 3: 67ra8. PMID 21270339 DOI: 10.1126/Scitranslmed.3001975  0.73
2011 Wahl D, Gatza E, Opipari A, Sundberg T, Reddy P, Liu C, Glick G, Ferrara J. Manipulation of the Bioenergetics of Alloreactive T Cells Leads to Their Selective Apoptosis and Arrests Graft Versus Host Disease Biology of Blood and Marrow Transplantation. 17: S149. DOI: 10.1016/J.Bbmt.2010.12.003  0.714
2010 Wahl DR, Petersen B, Warner R, Richardson BC, Glick GD, Opipari AW. Characterization of the metabolic phenotype of chronically activated lymphocytes. Lupus. 19: 1492-501. PMID 20647250 DOI: 10.1177/0961203310373109  0.626
2009 Sundberg TB, Swenson L, Wahl DR, Opipari AW, Glick GD. Apoptotic signaling activated by modulation of the F0F1-ATPase: implications for selective killing of autoimmune lymphocytes. The Journal of Pharmacology and Experimental Therapeutics. 331: 437-44. PMID 19706792 DOI: 10.1124/Jpet.109.156422  0.719
Show low-probability matches.